10x Genomics (TXG) Short-term Investments (2020 - 2026)

10x Genomics has disclosed Short-term Investments across 7 years of filings, most recently posting $49.5 million for Q2 2026.

• In Q2 2026, Short-term Investments changed 0.06% year-over-year to $49.5 million; the TTM figure through Jun 2026 stood at $49.5 million (changed 0.06% YoY), while the FY2025 annual figure was $49.4 million, changed 0.22% from the prior year.
• Short-term Investments came in at $49.5 million for Q2 2026 at 10x Genomics, roughly flat from $49.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $226.8 million in Q1 2022 to a low of $269000.0 in Q2 2024.
• Average Short-term Investments over 5 years is $86.5 million, with a median of $49.6 million recorded in 2026.
• Year-over-year, Short-term Investments soared 780025.0% in 2022 and slumped 99.59% in 2024.
• Over 5 years, Short-term Investments stood at $210.2 million in 2022, then sank by 86.01% to $29.4 million in 2023, then soared by 67.74% to $49.3 million in 2024, then gained by 0.22% to $49.4 million in 2025, then gained by 0.16% to $49.5 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $49.5 million in Q2 2026, $49.6 million in Q1 2026, and $49.4 million in Q4 2025.